comparemela.com

Latest Breaking News On - Oncology virtual - Page 1 : comparemela.com

Allogene Therapeutics Announces Q2 Investor Conference Participation

SOUTH SAN FRANCISCO, Calif., April 09, 2024 Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer and.

Christine-cassiano
Nasdaq
Allogene-therapeutics-inc
Corporate-affairs-brand-strategy
Twitter
Securities-life-sciences-conference
Goldman-sachs
Linkedin
Genuity-horizons
Oncology-virtual
Life-sciences-conference
Markets-global-healthcare-conference

Nkarta to Participate at Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural.

Greg-mann
Nasdaq
Nkarta-inc
Annual-needham-virtual-healthcare
Genuity-horizons
Oncology-virtual
Investor-contact
Nasdaq-nktx
Jakarta
Nc

IDEAYA Biosciences to Participate in Upcoming April 2023 Investor Relations Event

/PRNewswire/ IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted.

Li-watsek
Yujiro-hata
Nasdaq
Equity-research-analyst
Biosciences-inc
Exchange-commission
Oncology-virtual
Chief-executive-officer
Vice-president
Equity-research
Annual-report
Chief-financial

Cidara Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, March 31, 2023 Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to improve the standard of care for patients facing serious diseases,. | March 31, 2023

San-diego
California
United-states
Jeffrey-stein
Veronica-eames
Brian-ritchie
Lifesci-communications
Nasdaq
Globenewswire-inc
Panel-discussion
Cidara-therapeutics-inc
Chief-executive-officer

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.